Aurantoside C Targets and Induces Apoptosis in Triple Negative Breast Cancer Cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aurantoside C Targets and Induces Apoptosis in Triple Negative Breast Cancer Cells
Authors
Keywords
-
Journal
Marine Drugs
Volume 16, Issue 10, Pages 361
Publisher
MDPI AG
Online
2018-10-02
DOI
10.3390/md16100361
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Crambescidin 800, Isolated from the Marine Sponge Monanchora viridis, Induces Cell Cycle Arrest and Apoptosis in Triple-Negative Breast Cancer Cells
- (2018) Sumi Shrestha et al. Marine Drugs
- Stellettin B induces apoptosis in human chronic myeloid leukemia cells via targeting PI3K and Stat5
- (2017) Yali Chen et al. Oncotarget
- Anti-proliferation of triple-negative breast cancer cells with physagulide P: ROS/JNK signaling pathway induces apoptosis and autophagic cell death
- (2017) Pei Yu et al. Oncotarget
- FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer
- (2016) L Marzi et al. BRITISH JOURNAL OF CANCER
- Dual Inhibition of Key Proliferation Signaling Pathways in Triple-Negative Breast Cancer Cells by a Novel Derivative of Taiwanin A
- (2016) Yueh-Hsiung Kuo et al. MOLECULAR CANCER THERAPEUTICS
- Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases
- (2016) Per Hydbring et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer
- (2016) Abderrahim El Guerrab et al. Oncotarget
- Stellettin B Induces G1 Arrest, Apoptosis and Autophagy in Human Non-small Cell Lung Cancer A549 Cells via Blocking PI3K/Akt/mTOR Pathway
- (2016) Ran Wang et al. Scientific Reports
- Cyproheptadine, an antihistaminic drug, inhibits proliferation of hepatocellular carcinoma cells by blocking cell cycle progression through the activation of P38 MAP kinase
- (2015) Yu-Min Feng et al. BMC CANCER
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The re-emergence of natural products for drug discovery in the genomics era
- (2015) Alan L. Harvey et al. NATURE REVIEWS DRUG DISCOVERY
- Targeted Therapies for Triple-Negative Breast Cancer: Combating a Stubborn Disease
- (2015) Murugan Kalimutho et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Isoliensinine induces apoptosis in triple-negative human breast cancer cells through ROS generation and p38 MAPK/JNK activation
- (2015) Xiyu Zhang et al. Scientific Reports
- New Strategies for Triple-Negative Breast Cancer--Deciphering the Heterogeneity
- (2014) I. A. Mayer et al. CLINICAL CANCER RESEARCH
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- In Vitro Antitumor Activity of Stellettin B, a Triterpene from Marine Sponge Jaspis stellifera, on Human Glioblastoma Cancer SF295 Cells
- (2014) Sheng-An Tang et al. Marine Drugs
- Marine Sponge Derived Natural Products between 2001 and 2010: Trends and Opportunities for Discovery of Bioactives
- (2014) Mohammad Mehbub et al. Marine Drugs
- Methotrexate Inhibits NF-κB Activity Via Long Intergenic (Noncoding) RNA-p21 Induction
- (2014) Charles F. Spurlock et al. Arthritis & Rheumatology
- Cdks, cyclins and CKIs: roles beyond cell cycle regulation
- (2013) S. Lim et al. DEVELOPMENT
- Hinokitiol Inhibits Cell Growth through Induction of S-Phase Arrest and Apoptosis in Human Colon Cancer Cells and Suppresses Tumor Growth in a Mouse Xenograft Experiment
- (2013) Youn-Sun Lee et al. JOURNAL OF NATURAL PRODUCTS
- Finding chemo: the search for marine-based pharmaceutical drugs active against cancer
- (2013) Sivanjah Indumathy et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Modulation of Sensitivity to Antitumor Agents by Targeting the MAPK Survival Pathway
- (2012) Giacomo Cossa et al. CURRENT PHARMACEUTICAL DESIGN
- Aurantoside K, a New Antifungal Tetramic Acid Glycoside from a Fijian Marine Sponge of the Genus Melophlus
- (2012) Rohitesh Kumar et al. Marine Drugs
- Blockade of NFκB activity by Sunitinib increases cell death in Bortezomib-treated endometrial carcinoma cells
- (2012) Anabel Sorolla et al. Molecular Oncology
- Akt, FoxO and regulation of apoptosis
- (2011) Xinbo Zhang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Adjuvant trastuzumab with chemotherapy is effective in women with small, node-negative, HER2-positive breast cancer
- (2011) Heather L. McArthur et al. CANCER
- Aurantoside J: a New Tetramic Acid Glycoside from Theonella swinhoei. Insights into the Antifungal Potential of Aurantosides
- (2011) Rihab F. Angawi et al. Marine Drugs
- Triple-Negative Breast Cancer: An Unmet Medical Need
- (2011) C. A. Hudis et al. ONCOLOGIST
- Marine Natural Products Chemistry: Past, Present, and Future
- (2010) Robert J. Capon AUSTRALIAN JOURNAL OF CHEMISTRY
- Fisetin, a Dietary Flavonoid, Induces Cell Cycle Arrest and Apoptosis through Activation of p53 and Inhibition of NF-Kappa B Pathways in Bladder Cancer Cells
- (2010) Jing Li et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Triple-negative breast cancer: Present challenges and new perspectives
- (2010) Franca Podo et al. Molecular Oncology
- Deconstructing the molecular portraits of breast cancer
- (2010) Aleix Prat et al. Molecular Oncology
- Molecular Stratification of Triple-Negative Breast Cancers
- (2010) C. M. Perou ONCOLOGIST
- Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer
- (2009) B. Corkery et al. ANNALS OF ONCOLOGY
- Constitutive activation of nuclear factor-κB is preferentially involved in the proliferation of basal-like subtype breast cancer cell lines
- (2009) Noritaka Yamaguchi et al. CANCER SCIENCE
- DIXDC1 targets p21 and cyclin D1 via PI3K pathway activation to promote colon cancer cell proliferation
- (2009) Lei Wang et al. CANCER SCIENCE
- Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype
- (2008) M. C.U. Cheang et al. CLINICAL CANCER RESEARCH
- Natural products in drug discovery
- (2008) A HARVEY DRUG DISCOVERY TODAY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now